Euphrasia officinalis
Euphrasia officinalis · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Euphrasia officinalis is a medicinal plant whose leaf extracts, prepared through ethanol, acetone, or ethyl acetate, have garnered significant scientific interest. These preparations are rich in bioactive chemicals such as rutin, ellagic acid, quercetin 3-O-glucoside, and isorhamnetin-3-O-rutinoside. The plant demonstrates diverse pharmacological activities, acting as an antioxidant and an inhibitor of 5-lipoxygenase, 5-HT, and 11B-HSD. Due to these properties, research focuses on its therapeutic potential for addressing eye disorders, memory loss, and Alzheimer's disease. Consequently, the phytochemical profile of this species offers promising pathways for managing complex neurological and ocular conditions.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Orobanchaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Leaf
Classification
Common Names
Euphrasia officinalis is a versatile botanical species known by a wide variety of regional and traditional names. In certain linguistic circles, it is referred to by the common moniker Effros or the more formal Eufrasia officinale. Various European cultures have developed their own unique labels, such as the Dutch Beklierde ogentroost and the German Echter Augentrost. It is also recognized by the French term Casse-lunettes, reflecting its historical associations. These diverse names highlight the plant's widespread recognition across different botanical traditions.
Sources: Catalogue of Life (COL)
Taxonomy
Euphrasia officinalis belongs to the vast kingdom Plantae, representing a diverse branch of the natural world. Within this biological hierarchy, the species is classified under the class Equisetopsida. It further falls into the order Lamiales, a group that shares specific structural characteristics. As a member of the Orobanchaceae family, it plays a unique role in its ecological niche. Ultimately, this plant is defined by its placement within the genus Euphrasia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Orobanchaceae |
| Genus | Euphrasia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Euphrasia officinalis exhibits a remarkably diverse geographical range that spans multiple continents and climates. In the southern hemisphere, it can be found across Antarctica, the Subantarctic Islands, and the Falkland Islands. Its presence extends significantly into Asia-Temperate regions, specifically within the Caucasus, Transcaucasus, and the vast stretches of Siberia. Furthermore, the species is well-established in Western Asia, notably throughout Türkiye. Finally, its distribution reaches into Europe, where it is commonly found across the Baltic States of Eastern Europe.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Euphrasia officinalis is a distinct herb characterized by its sturdy, self-supporting growth form. This plant typically maintains a modest stature, with heights reaching a maximum of 0.5 meters. Depending on its environment, its development can vary significantly, sometimes appearing as small as 0.02 meters. In many instances, the species establishes a more consistent presence with a minimum height of around 0.221 meters. Such variability in size allows this herb to adapt effectively to its various natural habitats.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Euphrasia officinalis, commonly known as eyebright, has emerged as a significant subject of interest due to its diverse medicinal properties. Recent research highlights that this plant possesses notable antioxidant capacity, which may help combat oxidative stress. Furthermore, studies have demonstrated that its extracts exhibit anticholinesterase activity, a key factor in neurological health. These combined biological activities suggest that the plant could play a vital role in protecting against neurodegenerative conditions like Alzheimer's disease. Consequently, the therapeutic potential of eyebright offers promising avenues for the development of new pharmaceuticals and functional supplements.
Compounds
Euphrasia officinalis is a medicinal plant that possesses a rich profile of bioactive polyphenolic compounds. Recent research has identified that the plant contains several key phytochemicals, including rutin and ellagic acid. Furthermore, the optimized extracts of the species are found to contain quercetin 3-O-glucoside and isorhamnetin-3-O-rutinoside. These specific compounds contribute to the plant's significant antibacterial potential, particularly against Gram-positive bacteria. By understanding this chemical composition, scientists can better utilize the plant as a source for novel natural antibacterial agents.
Conditions
Euphrasia officinalis is utilized in traditional folk medicine to treat various eye disorders and general eye problems. Research indicates that this plant possesses neuroprotective properties that may help in treating Alzheimer's disease. Furthermore, its extracts have demonstrated the ability to treat LPS-stimulated inflammation by inhibiting specific signaling pathways. This anti-inflammatory effect is achieved by successfully treating the expression of the iNOS gene and protein. These diverse therapeutic applications highlight the medicinal versatility of the species across different biological systems.
Preparations
Euphrasia officinalis is prepared as ethanol and acetone extracts to evaluate its antibacterial activity and potential mode of action. The plant is also prepared as ethyl acetate extracts, which have demonstrated significant neuroprotective and antioxidant properties in various assays. Researchers utilize Euphrasia officinalis extracts in diverse studies to explore their chemical characterization and therapeutic potential. Furthermore, the plant is prepared as a leaf extract specifically for the green synthesis of gold nanoparticles. These various forms of Euphrasia officinalis extracts serve as a foundation for investigating new applications in medicine and pharmacology.
Parts used
Euphrasia officinalis serves as a vital source of bioactive compounds, specifically through the utilization of its leaf extract. In recent scientific advancements, these leaves have been employed in the green synthesis of gold nanoparticles to create highly biocompatible medicinal tools. This specialized extract facilitates the production of nanoparticles that can effectively target and inhibit inflammatory pathways within macrophage cells. By leveraging the natural properties of the plant's foliage, researchers have successfully suppressed key inflammatory mediators like nitric oxide and various cytokines. Ultimately, the use of Euphrasia officinalis leaves demonstrates significant potential for developing new treatments for inflammatory-mediated diseases.